Policy makers face a growing range of illicit drugs and aggressive marketingBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4676 (Published 11 November 2009) Cite this as: BMJ 2009;339:b4676
- Rory Watson
Europe’s antidrug policies must adapt to an increasingly complex and volatile market in synthetic recreational drugs, says the latest annual report by the Lisbon based European Monitoring Centre for Drugs and Drug Addiction.
Overall there has been no appreciable improvement in reducing the use of cocaine and heroin, but there are signs that cannabis is losing its popularity, especially among young people. However, the report emphasises the moving target that policy makers face as suppliers become more innovative in their products and ability to circumvent controls.
It identifies a growing trend: the emergence of a “legal highs” market. This involves the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial